SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-054574
Filing Date
2020-10-13
Accepted
2020-10-13 07:27:42
Documents
2
Period of Report
2020-10-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1621
2 POA DOCUMENT poa.txt EX-24.3_941225 3554
  Complete submission text file 0001209191-20-054574.txt   6584
Mailing Address MERCK MEDCO MANAGED CARE INC 100 SUMMIT AVE MONTVALE NJ 07645
Business Address
ATIEH MICHAEL G (Reporting) CIK: 0001072501 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39112 | Film No.: 201234586

Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Issuer) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences